Correspondence
Mega-block sampling is not essential for clinically relevant staging of rectal carcinoma resection specimens
First published: 27 June 2019
No abstract is available for this article.
- 1Loughrey MB, Quirke P, Shepherd NA. Dataset for histopathological reporting of colorectal cancer. 4th ed. London: Royal College of Pathologists, 2018.
- 2Foschini MP, Baldovini C, Ishikawa Y, Eusebi V. The value of large sections in surgical pathology. Int. J. Breast Cancer 2012; 2012; 776.
- 3Chang F, Deere H, Mahadeva U, George S. Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy: practical guidelines and current issues. Am. J. Clin. Pathol. 2008; 129; 252–778.
- 4Hanley JA, Lippman-Hand A. If nothing goes wrong, is everything all right? Interpreting zero numerators. JAMA 1983; 249; 1743–1745.
- 5Moran BJ, Holm T, Brannagan G et al. The English national low rectal cancer development programme: key messages and future perspectives. Colorect. Dis. 2014; 16; 173–178.
- 6Gollins S, West N, Sebag-Montefiore D et al. A prospective phase II study of pre-operative chemotherapy then short-course radiotherapy for high risk rectal cancer: COPERNICUS. Br. J. Cancer 2018; 119; 697–706.
